Bristol-Myers Squibb Co. discovers, develops, and commercializes medicines across a range of therapeutic areas, including cardiovascular disease, cancer, and immune-related disorders. The company places a strong emphasis on immuno-oncology, where it holds a leading position in drug development. Bristol-Myers Squibb generates nearly 70% of its total revenue from the United States, reflecting greater reliance on the US market than many of its industry peers.